The more than $6 billion that the Trump administration awarded to pharmaceutical giants Novavax, Pfizer, Sanofi, and Johnson & Johnson to develop vaccines for the Wuhan coronavirus (covid-19) cannot be publicly accounted for with transparency because it was first funneled through a defense contract…